| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2001-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16bc52a26712356f3054008c53110467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_776dea23bfd3d4dd22ee35d44b08cf46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38d7087fa52813bd7e42bc8be9707df3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb194efd8d021cee48dcd9b093ec4c8f |
| publicationDate |
2001-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1129725-A2 |
| titleOfInvention |
Oligonucleotide conjugates |
| abstract |
The present invention relates to an oligonucleotidenconjugate, comprising: (a) an oligonucleotide at least partnof whose sequence is complementary to an intracellularnnucleic acid sequence; and (b) a somatostatin analog. Thenpresent invention also relates to a medicament containingnthis oligonucleotide conjugate, preferably for treatingntumors in which the somatostatin receptor (SSTR) isnoverexpressed. |
| priorityDate |
2000-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |